Niagen Bioscience management participates in Longevity Investors Conference panel

PUBT · 3d ago
Niagen Bioscience management participates in Longevity Investors Conference panel
  • Niagen Bioscience will attend the Longevity Investors Conference in Gstaad, Switzerland, Sept. 14-17, 2026.
  • CEO Rob Fried is scheduled for a consumer health investment panel on Sept. 16, 2026, 14:50-15:30 CEST.
  • CFO Ozan Pamir will hold in-person one-on-one investor meetings during the conference.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Niagen Bioscience Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260902223169) on September 02, 2026, and is solely responsible for the information contained therein.